Legal Opinion
Goodell v. Bayer HealthCare Pharmaceuticals Inc.
District Court, D. Massachusetts
Decided September 30, 2019No. 1:18-cv-10694Unknown
1Opinion
UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS STEPHEN GOODELL, * * Plaintiff, * * v. * Civil Action No. 18-cv-10694-IT * BAYER HEALTHCARE * PHARMACEUTICALS INC., et al., * * Defendants. * MEMORANDUM & ORDER September 30, 2019 TALWANI, D.J. In 2010, Plaintiff Stephen Goodell was administered an injection of Magnevist in connection with an MRI. Magnevist is a gadolinium-based contrast agent (“GBCA”) manufactured, marketed, and sold by Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Corporation, and Bayer Healthcare LLC (collectively “Bayer”). Plaintiff alleges that the…
2Cases cited23 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Swierkiewicz v. Sorema N. A.Supreme Court of the United States · 2002
- Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty.Supreme Court of the United States · 2017
- Wyeth v. LevineSupreme Court of the United States · 2009
- Haley v. City of BostonCourt of Appeals for the First Circuit · 2011
18 more not listed; retrieve them via the Exa API.